Transforming Growth Factor-Beta in Cancer Therapy, Volume I (eBook, PDF)

Basic and Clinical Biology
Redaktion: Jakowlew, Sonia B.

• Format: PDF

Produktbeschreibung

Transforming Growth Factor-ß in Cancer Therapy, Volumes 1 and 2, provide a compendium of findings about the role of transforming growth factor-ß (TGF-ß) in cancer treatment and therapy. The first volume, Basic and Clinical Biology, is divided into three parts. Part I presents basic concepts of transforming growth factor-ß signaling in normal physiology and cancer pathobiology. Part II investigates transforming growth factor-ß superfamily members in normal and tumor biology. Part III details transforming growth factor-ß in inflammation and fibrosis.

This volume's companion, Cancer Treatment and Therapy, examines transforming growth factor-ß in several developing and advanced cancers and discusses methods of treatment and therapy. Together, Transforming Growth Factor-ß in Cancer Therapy, Volumes 1 and 2, provide researchers and clinicians with a comprehensive and cutting-edge reference for the findings about the role of transforming growth factor-ß in biology and cancer treatment.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Humana Press
• Seitenzahl: 735
• Erscheinungstermin: 1. Januar 2010
• Englisch
• ISBN-13: 9781597452922
• Artikelnr.: 37341016

Autorenporträt

Sonia Jakowlew, National Cancer Institute, Rockville, MD, USA

Inhaltsangabe

Basic Concepts of TGF-? Signaling in Normal Physiology and Cancer Pathobiology.- Component Hardware for Transforming Growth Factor-? Signal Transduction: TGF-? Ligands, TGF-? Receptors, and Smads.- TGF-? Signaling in Homeostasis and Cancer.- TGF-? Availability: Latent TGF-? and Latent TGF-? Binding Proteins.- Biological Functions of Latent TGF-?-Binding Proteins and Activation of TGF-?.- Regulators of Smad2/3 Transcription and Phosphorylation.- Interaction of Smad4 and Embryonic Liver Fodrin-?-spectrin in Hyperplasia, Neoplasia, and Tumor Suppression.- Regulation of Smad Activity by Phosphorylation.- Nuclear Targeting of TGF-?-Activated Smads in Normal and Tumor Biology.- Ski, SnoN, and Akt as Negative Regulators of Smad Activity: Balancing Cell Death and Cell Survival.- Transforming Growth Factor-? in Cancer Therapy: Smurfs in TGF-? Signaling and Regulation of Bone Homeostasis and Cancer.- Involvement of km23 Dynein Light Chains in TGF ? Signaling.- TGF-? Signaling in Fibroblastic Cells and Oncogenesis.- Mechanisms of TGF-?-Induced Apoptosis in Cancer Cells.- Mechanisms of Cell Cycle Regulation by TGF-? Disabled in Cancer.- Transforming Growth Factor-? in Cancer Therapy.- TGF-? and Smad Signaling in Transcriptome Reprogramming During EMT.- Functional Interactions Between MMPs and TGF-? in Normal and Tumor Tissue.- Cooperation Between TGF-? and Wnt Pathway Components in Regulating Mesenchymal Stem Cell Function.- Interaction of Oncogenic Ras and TGF?1 Signaling in Cancer: Lessons From the Multistage Skin Carcinogenesis Model.- TGF-? Superfamily Members in Normal and Tumor Biology.- Proteomics Analysis of TGF? Superfamily Members.- Mullerian Inhibiting Substance: A Potential Nontoxic, Naturally Occurring Therapeutic Agent for Certain HumanCancers.- Activins, Inhibins, and Bone Morphogenetic Proteins as Modulators and Biomarkers of Prostate Cancer Progression.- Bone Morphogenic Proteins and Angiogenesis in Developing Tumors.- Histone Methyltransferase and Smad Interactions in BMP Signaling.- Endoglin (CD105): A Strong Candidate for Immunologic Targeting of Tumor Neovasculature in Human Malignancies.- Activins and Inhibins in Cancer Progression.- Bone Morphogenetic Proteins/Growth Differentiation Factors and Smad Activation in Ovarian Granulosa Cells and Carcinoma.- Regulation of the Transforming Growth Factor-? Superfamily by Betaglycan.- Uterine Sensitization Associated Gene-1: A Bone Morphogenetic Protein Antagonist with a Role in Kidney.- Role of Betaig-h3 Gene in Carcinogenesis.- Activins and the Liver.- Myostatin Signaling in Normal and Tumor Cells.- TGF-? in Inflammation and Fibrosis.- Triterpenoids, Vitamin D, and TGF-?/Smad Signaling in Inflammation and Cancer.- Thrombospondin-Dependent Activation of Latent TGF-? in Fibrosis and Disease.- TGF-? in Pulmonary Fibrosis.- The Role of TGF-? in Bleomycin Induced Pulmonary Fibrosis.- Smads in the Fibrotic Response: Findings in the Smad3 Knockout Mouse.- TGF-? Signaling in Renal Fibrosis and Inflammation: Gene Therapy Using Ultrasound-Microbubble-Mediated Inducible Smad7.- Transforming Growth Factor-? Peptide Signaling in Pulmonary Development, Bronchopulmonary Dysplasia, Fibrosis, and Emphysema.- The Role of TGF-? in Radiation and Chemotherapy Induced Pulmonary Fibrosis: Inhibition of TGF-? as a Novel Therapeutic Strategy.- Negative Regulation of the TGF-? Family Signal Pathway by Inhibitory Smads and Their Involvement in Cancer and Fibrosis.- TGF-?-Related Antifibrotic Strategies in the Eye.- Transforming Growth Factor-? in CutaneousTissue Repair.- Topical Application of TGF-?1 Peptide Inhibitors for the Therapy of Skin Fibrosis.- Overexpressed Truncated TGF-? Type II Receptor Inhibits Fibrotic Behavior of Keloid Fibroblasts In Vitro and Experimental Scar Formation In Vivo.

Rezensionen

From the reviews:

"This volume provides a comprehensive review of TGF-beta regulation, signaling, and cellular function in both normal and tumor biology. ... will be of use to individuals interested in the role of TGF-beta in the development of cancer and fibrosis. This will likely benefit readers interested in TGF-beta in the pathogenesis of disease ... . also be a resource for those interested in the complex intracellular signaling cascades elicited by TGF-beta in normal and altered cells." (James P Luyendyk, Doody's Review Service, May, 2008)